The Recall Desk
LowFDA (Devices)·Z-0446-2016·Announced 2015-12-23

Edwards Lifesciences Recalls IV Administration Sets for Regulatory Submission

Edwards Lifesciences is recalling 147,350 units of IV Administration Sets because an additional FDA submission is required to support commercialization.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is driven by a regulatory documentation requirement (additional FDA submission) rather than a product defect or safety hazard, fitting the 'documentation issues' criterion for a Low severity score.

Plain-English summary

Edwards Lifesciences, LLC is recalling 147,350 units of Intravascular (IV) Administration Sets. The affected models include 54IV12, 54IV22, 54IV32, MK2450, 54IV42, MK132, MK2156, MK2270, MK2292, MK2300, MK2374, MK2394, MK2508, and MK2227.

The recall was initiated due to the requirement of an additional FDA submission to support the commercialization (clearance) of the devices. The source text does not indicate that this is a safety recall or that any adverse health consequences have been reported.

The distribution pattern is listed as US. The source text does not provide specific instructions for consumers or healthcare providers on how to handle the recalled units.

The recalled product

Product
Intravascular (IV) Administration Sets, Model No. 54IV12, 54IV22, 54IV32, MK2450, 54IV42, MK132, MK2156, MK2270, MK2292, MK2300, MK2374, MK2394, MK2508, MK2227
Affected units
147,350

Distribution

Distribution scope not specified by the agency.